CDT EQUITY INC. Debt Instrument, Face Amount
CDT EQUITY INC. (CDT) had Debt Instrument, Face Amount of $5.70 million as of 2024-11-30, per its S-1 filed 2026-09-08.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2026-09-08
- 2024-11-30: Debt Instrument, Face Amount $5.70M.
- 2023-03-07: Debt Instrument, Face Amount $1.50M.
- 2022-11-01: Debt Instrument, Face Amount $3.30M.
- 2021-11-04: Debt Instrument, Face Amount $300.00K.
USD
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2024-11-30 | $5.70M S-1 · filed 2026-09-08 |
| 2023-03-07 | $1.50M 10-Q · filed 2023-05-15 |
| 2022-11-01 | $3.30M 10-K · filed 2024-04-16 |
| 2021-11-04 | $300.00K 10-K · filed 2023-03-28 |
| 2021-05-27 | $1.40M 10-Q/A · filed 2024-11-14 |
GBP
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2022-11-01 | 3.00M GBP 10-K · filed 2024-04-16 |
| 2021-05-27 | 1.00M GBP 10-Q/A · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |